Search Within

Andrew D Seidman

  1. "Psychiatry and Behavioral Sciences, Department of"
Formats
  1. Journal Article (27)
  2. Meeting Abstract (15)
  3. Conference Paper (3)
Groups
  1. Breast Medicine Service (45)
  2. Department of Medicine (45)
  3. Psychiatry and Behavioral Sciences, Department of (45)
  4. Solid Tumor Oncology Division (45)
  5. Survivorship Research (43)
  6. Behavioral Sciences Service (40)

More Groups

People
  1. Clifford Hudis (38)
  2. Larry Norton (38)
  3. Teresa Gilewski (38)
  4. Violante Currie (24)
  5. Nancy Sklarin (22)
  6. Mary Ellen Moynahan (18)

More People

Years
  1. 2020 (1)
  2. 2019 (2)
  3. 2018 (4)
  4. 2017 (1)
  5. 2014 (1)
  6. 2013 (1)

More Years

Publications
  1. Journal of Clinical Oncology (11)
  2. Breast Cancer Research and Treatment (8)
  3. Cancer Research (4)
  4. Clinical Cancer Research (4)
  5. Seminars in Oncology (3)
  6. Clinical Breast Cancer (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (12)
  2. Springer (10)
  3. American Association for Cancer Research (9)
  4. Elsevier Inc. (7)
  5. Oxford University Press (3)
  6. Informa Healthcare (1)

More Publishers

Results (45)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification
    Journal Article

    Seidman, A. D.; Fornier, M. N.; Esteva, F. J.; Tan, L.; Kaptain, S.; Bach, A.; Panageas, K. S.; Arroyo, C.; Valero, V.; Currie, V.; more...
    Journal of Clinical Oncology (2001)

    Fulltext@MSK | Save
  • Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma
    Journal Article

    Fornier, M. N.; Seidman, A. D.; Theodoulou, M.; Moynahan, M. E.; Currie, V.; Moasser, M.; Sklarin, N.; Gilewski, T.; D'Andrea, G.; Salvaggio, R.; more...
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • An immunotherapeutic approach to treatment of breast cancer: Focus on trastuzumab plus paclitaxel
    Journal Article

    Gilewski, T.; Seidman, A.; Norton, L.; Hudis, C.
    Cancer Chemotherapy and Pharmacology (2000)

    Fulltext@MSK | Save
  • Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer
    Journal Article

    D'Andrea, G.; Fennelly, D.; Norton, L.; Baselga, J.; Gilewski, T.; Hudis, C.; Moynahan, M. E.; Raptis, G.; Sklarin, N.; Surbone, A.; more...
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • 5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II study
    Journal Article

    Hudis, C.; Fornier, M.; Riccio, L.; Lebwohl, D.; Crown, J.; Gilewski, T.; Surbone, A.; Currie, V.; Seidman, A.; Reichman, B.; more...
    Journal of Clinical Oncology (1999)

    Fulltext@MSK | Save
  • Sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide for resectable high-risk breast cancer: Feasibility and efficacy
    Journal Article

    Hudis, C.; Seidman, A.; Baselga, J.; Raptis, G.; Lebwohl, D.; Gilewski, T.; Moynahan, M.; Sklarin, N.; Fennelly, D.; Crown, J. P. A.; more...
    Journal of Clinical Oncology (1999)

    Fulltext@MSK | Save
  • Lack of increased cardiac toxicity with sequential doxorubicin and paclitaxel
    Journal Article

    Hudis, C.; Riccio, L.; Seidman, A.; Baselga, J.; Currie, V.; Fennelly, D.; Gilewski, T.; Lebwohl, D.; Moynahan, M.; Raptis, G.; more...
    Cancer Investigation (1998)

    Fulltext@MSK | Save
  • Phase II study of semisynthetic paclitaxel in metastatic breast cancer
    Journal Article

    Hudis, C.; Riccio, L.; Holmes, F.; Seidman, A.; Baselga, J.; Currie, V.; Fennelly, D.; Gilewski, T.; Moynahan, M.; Raptis, G.; more...
    European Journal of Cancer (1997)

    Fulltext@MSK | Save
  • Event-free survival after sequential dose-dense doxorubicin (A), paclitaxel (T) and cyclophosphamide (C) in women (pts) with ≥ 4 positive (+) axillary lymph nodes (LN)
    Meeting Abstract

    Hudis, C.; Seidman, A.; Raptis, G.; Baselga, J.; Gilewski, T.; Fennelly, D.; Lebwohl, D.; Surbone, A.; Currie, V.; Moynahan, M.; more...
    Breast Cancer Research and Treatment (1996)

    Fulltext@MSK | Save
  • Sequential adjuvant therapy: The Memorial Sloan-Kettering Cancer Center experience
    Journal Article

    Hudis, C.; Seidman, A.; Raptis, G.; Fennelly, D.; Gilewski, T.; Baselga, J.; Theodoulou, M.; Sklarin, N.; Moynahan, M.; Surbone, A.; more...
    Seminars in Oncology (1996)

    Fulltext@MSK | Save